Each year, In Vivo spotlights the next wave of entrepreneurs and innovators making a difference in the biopharma, medtech and health technology sectors. The 30 Rising Leaders have been recognised for their achievements, talent, creativity and leadership and this year include four of Optimum’s fantastic clients. Firstly, Anthony DeBoer, VP of Business Development at Synaffix, […]
The 3rd annual listing of In Vivo’s ‘Rising Leaders’ has landed! Optimum is thrilled to see our brilliant clients from M Ventures, INKEF Capital, BioQube, Healthcap and Octarine recognised alongside other leading entrepreneurs and innovators in healthcare, from all across the globe. The 30 people spotlighted have been recognized for bringing something new to the […]
As part of its ‘Pharma Outlook for 2022’, leading healthcare publication, In Vivo, explored the outlook for US and EU venture capital funding in biopharma. Asking whether the sector can keep the momentum going for investments, it drew on the experience and insight of prominent investors [many among them our clients,] to provide comment on […]
